Colon Cancer
Treating metastatic colonic cancer – phase III study comparing FOFOX6 + Bevacizumab to optimum systemic therapy combined with cytoreductive surgery and interoperational perfusion of hypothermic chemotherapy to the peritoneum combined with FOFOX6 + Bevacizumab or optimal systemic therapy for patients with metastatic colonic cancer in the peritoneal cavity only.
Researchers:
Dr. Nissan and Dr. Rothenberg.